23 results on '"Schellens Jhm."'
Search Results
2. Abstract OT1-03-10: A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or -2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study)
3. Disease Progression/Clinical Outcome Model for Castration‐Resistant Prostate Cancer in Patients Treated With Eribulin
4. Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration‐Resistant Prostate Cancer Treatment With Eribulin
5. Quantification of taxanes in biological matrices: a review of bioanalytical assays and recommendations for development of new assays
6. Pharmacogenetics in the Cancer Clinic: From Candidate Gene Studies to Next-Generation Sequencing
7. Quantitative determination of erlotinib and O-desmethyl erlotinib in human EDTA plasma and lung tumor tissue
8. The Dutch Vision of Clinical Pharmacology
9. Novel Clinical Trial Designs for Innovative Therapies
10. Propofol extravasation in a breast cancer patient
11. PK/PD Model of Indisulam and Capecitabine: Interaction Causes Excessive Myelosuppression
12. Dual topoisomerase I/II inhibitors
13. Phase I and pharmacologic study of BMS-181174 given as a 6 h infusion every 4 weeks to patients with advanced solid tumors
14. Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell line
15. Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours
16. The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitor
17. Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development
18. Pharmacokinetic profile and clinical efficacy of a once-daily ondansetron suppository in cyclophosphamide-induced emesis: a double blind comparative study with ondansetron tablets
19. Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours
20. Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor
21. Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration
22. Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair
23. Pharmacokinetic-dynamic relationship of cisplatin in vitro: simulation of an i.v. bolus and 3 h and 20 h infusion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.